IMS acquires Russian consultancy
This article was originally published in Scrip
IMS Health, the market intelligence and statistics consultancy, has acquired RMBC, which provides pharmaceutical market intelligence and analytics for the Russian market. RMBC gathers retail and hospital prescribing data from Russia, Ukraine, Belarus, Kazakhstan and Uzbekistan. IMS says that Russia and the Commonwealth of Independent States together represent a pharmaceutical market worth $10 billion that is growing at 10-15% annually.